BERINERT

This brand name is authorized in Austria, Brazil, Canada, Croatia, Cyprus, Estonia, Finland, France, Ireland, Israel, Japan, Lithuania, Malta, Poland, Romania, Spain, Turkey, UK.

Active ingredients

The drug BERINERT contains one active pharmaceutical ingredient (API):

1	C1-inhibitor UNII 6KIC4BB60G - HUMAN C1-ESTERASE INHIBITOR
	C1 inhibitor is a single chain glycoprotein found in plasma and a member of the serine protease inhibitor, or serpin, superfamily of proteins. C1 inhibitor inhibits the complement system by binding C1r and C1s and is the most important inhibitor of contact activation, regulating the contact system and the intrinsic coagulation pathway by binding to and inactivating kallikrein and factor XIIa.
	Read more about C1-inhibitor

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B06AC01	C1-inhibitor, plasma derived	B Blood and blood forming organs → B06 Other hematological agents → B06A Other hematological agents → B06AC Drugs used in hereditary angioedema
Discover more medicines within B06AC01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	502614070006902, 502617100007902, 502621040010703, 502621040010803
CA	Health Products and Food Branch	02352575, 02436078
EE	Ravimiamet	1351392, 1836503, 1836514, 1836525, 1836536, 1853816, 1853827, 1853838, 1853849
ES	Centro de información online de medicamentos de la AEMPS	70695, 79703, 82884, 82885
FI	Lääkealan turvallisuus- ja kehittämiskeskus	168119, 451428
FR	Base de données publique des médicaments	61846118
GB	Medicines & Healthcare Products Regulatory Agency	109220, 309211
HR	Agencija za lijekove i medicinske proizvode	HR-H-170893029, HR-H-323302356, HR-H-828344348, HR-H-917245852
IL	מִשְׂרַד הַבְּרִיאוּת	6677
JP	医薬品医療機器総合機構	6343426D1023, 6343426F1032
LT	Valstybinė vaistų kontrolės tarnyba	1090621
MT	Medicines Authority	MA665/00501, MA665/00502, MA665/00503, MA665/00504
PL	Rejestru Produktów Leczniczych	100212265, 100338807, 100383699, 100383707
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W58531001, W61669001, W65555001, W65555002, W65555003, W65559001, W65559002, W65559003
TR	İlaç ve Tıbbi Cihaz Kurumu	8681624980378